S&P/TSX Venture Composite Index

EQS-News: As Carmakers Invest More In Environmentally Conscious Materials, Supply Of Key Material Chinese Phosphate Is At Risk

Retrieved on: 
Sunday, November 27, 2022
EVS, TSX, ESG, Chemistry, DAN, Advertising, Cobalt, Research report, OTCQX, Miner, S&P/TSX Venture Composite Index, LFP, Risk, Blockchain.com, Lithium, Nickel, Lac, Western world, Rare-earth element, Electric battery, Fertilizer, Turner, Ariane

As Carmakers Invest More In Environmentally Conscious Materials, Supply Of Key Material Chinese Phosphate Is At Risk

Key Points: 
  • As Carmakers Invest More In Environmentally Conscious Materials, Supply Of Key Material Chinese Phosphate Is At Risk
    The issuer is solely responsible for the content of this announcement.
  • However, as more countries invest in LFPs, there will be a need for LFP production outside of China.
  • While the wet process has a historically higher cost, it is preferred in the Western world because it is more environmentally conscious.
  • Arianne Phosphate Inc. (OTCMKTS: DRRSF) is a phosphate mining company that might help meet the growing demand for phosphate used in batteries and fertilizer.

EQS-News: Arianne Phosphate Is Providing A Safe And Secure Alternative To Chinese Phosphate Close To Home

Retrieved on: 
Friday, November 11, 2022
Hydroelectricity, First Nations, Mining, LFP, Carbon, Microsoft, Risk, Advertising, Population, DAN, Lac, OTCQX, Government, Program, TSX, MENA, Blockchain.com, S&P/TSX Venture Composite Index, Lithium, Rare-earth element, Fertilizer, Dietary supplement, Ariane

China and Russia have recently suspended or minimized exports of phosphate, which is proving problematic to the supply chain and for manufacturers relying on Chinese phosphate.

Key Points: 
  • China and Russia have recently suspended or minimized exports of phosphate, which is proving problematic to the supply chain and for manufacturers relying on Chinese phosphate.
  • Similarly, the phosphate concentrates in the Middle East and North Africa are dependent on geopolitical stability that is often fluctuating.
  • Arianne Phosphate Inc. (OTCMKTS: DRRSF) is a promising phosphate mining company that can help meet the growing demand for phosphate used in batteries and fertilizer.
  • This allows Arianne to produce a high-purity and low-contaminant phosphate concentrate ideal for use in batteries and fertilizer.

EQS-News: If You’re Trying To Hedge Inflation, Phosphate Is A Commodity To Keep Your Eye On

Retrieved on: 
Friday, November 11, 2022
Federal, LFP, Investment, Risk, OTC, Advertising, Adoption, Fertilizer, Nickel, DAN, EVS, Lac, Commodity, OTCQX, Phosphate, Growth, Agriculture, TSX, Cobalt, S&P/TSX Venture Composite Index, Industry, Food, Blockchain.com, Lithium, Financial services

If Youre Trying To Hedge Inflation, Phosphate Is A Commodity To Keep Your Eye On

Key Points: 
  • If Youre Trying To Hedge Inflation, Phosphate Is A Commodity To Keep Your Eye On
    The issuer is solely responsible for the content of this announcement.
  • As people grapple with the ramifications of the recession, they are looking to hedge against rising inflation.
  • An inflation hedge is typically an investment intended to protect an investor against any significant decrease in the purchasing power of money.
  • Arianne Phosphate Inc. (OTC: DRRSF) is one of the promising phosphate mining companies that can respond to the growing demand for phosphate.

EQS-News: Arianne Phosphate Has Capacity To Meet Growing Demand As Electric Vehicles Transition To Lithium Iron Phosphate Batteries

Retrieved on: 
Monday, November 7, 2022
TSLA, Chemistry, OTCQX, Lithium, LFP, Research report, Risk, Industry, Manganese, OTC, EVS, MENA, S&P/TSX Venture Composite Index, TSX, Nickel, Blockchain.com, NASDAQ, Lac, Tesla, Advertising, DAN, Cobalt, Tesla, Inc., Efficiency, Electric battery, Rare-earth element, Fertilizer, African

For decades, companies specifically North American companies placed their bets on lithium-ion batteries, which rely heavily on lithium, cobalt, and nickel resources.

Key Points: 
  • For decades, companies specifically North American companies placed their bets on lithium-ion batteries, which rely heavily on lithium, cobalt, and nickel resources.
  • As such, due to factors ranging from supply chain concerns to cost and efficiency considerations, engineers and companies are now transitioning away from lithium-ion batteries with cobalt and nickel in favor of lithium iron phosphate batteries (LFP).
  • But North American companies, including Tesla, are hesitant to rely heavily on Chinese, Middle Eastern, and North African phosphate.
  • Arianne Phosphate Inc. (OTC: DRRSF) is one of the promising phosphate mining companies that can help meet the growing demand for phosphate for EVs.

Reliq Health Technologies, Inc. Files FY 2022 Annual Audited Financial Statements, Announces 485% Year-over-Year Increase in Revenues

Retrieved on: 
Wednesday, November 2, 2022
Nephrology, Medicaid, Growth, RHT, Population, RTM, ER, Mission statement, Hospital, GLOBE, WKN, COVID-19, Health care, Adoption, Company, Cardiology, Review, OTC, Center, Fiscal, Calendar, Cognizant, Software, Frankfurt Stock Exchange, Adult, CEO, Centers for Medicare & Medicaid Services, S&P/TSX Venture Composite Index, Nursing, Hospice, Patient, Elective surgery, Restatement (Second) of Contracts, SEDAR, Exercise, Blockchain.com, Time, Risk, Omicron, Physician, CMS, Logic, IFRS, DSL, Patient engagement in Canada, Income, Share repurchase, Hounslow and Richmond Community Healthcare NHS Trust, General number field sieve, Sale, Medicare, Quality of life, Pharmaceutical industry, Tutoring, Health insurance, Medicine, Accounting, Q3

We have now filed our annual audited financials for Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. FY 2022 was a period of tremendous growth for the Company.

Key Points: 
  • We have now filed our annual audited financials for Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. FY 2022 was a period of tremendous growth for the Company.
  • Revenues for the fiscal year increased by 485% to $8,551,807 for FY 2022 as compared to $1,462,165 for FY 2021.
  • During the twelve month period ending June 30, 2022 and subsequent, the Company:
    Increased sales 485% to $8,551,807 for FY 2022 relative to $1,462,165 for FY 2021.
  • Increased revenue from software and services by over 1,940% to $2,739,516 for FY 2022 (FY 2021 - $134,264).

Reliq Health Technologies, Inc. Files Q3 FY2022 Quarterly Financial Statements, Provides Corporate Update

Retrieved on: 
Tuesday, May 31, 2022
Physician, Risk, Software, Medicaid, Company, Centers for Medicare & Medicaid Services, Hounslow and Richmond Community Healthcare NHS Trust, CMS, Population, Ageing, EBITDA, ER, RHT, Hospital, RTM, Hospice, Patient, Nephrology, S&P/TSX Venture Composite Index, SEDAR, Mission statement, OTC, Quality of life, Review, Patient engagement in Canada, Health care, COVID-19, Nursing, Adult, DSL, Elective surgery, Medicare, Restatement (Second) of Contracts, Blockchain.com, Time, Omicron, FHIR, Sale, Cognizant, Adoption, Center, Logic, Growth, GLOBE, CEO, Cardiology, Pharmaceutical industry, Video game, Online gambling, Health insurance, Q3, Calendar

We have now filed our quarterly financials for Q3 Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.

Key Points: 
  • We have now filed our quarterly financials for Q3 Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.
  • The Company is also pleased to provide the following corporate update.
  • Reliq Health Technologies is a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market.
  • Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTC as RQHTF.

Reliq Health Technologies, Inc. Files Q2 FY2022 Quarterly Financial Statements, Provides Corporate Update

Retrieved on: 
Wednesday, March 2, 2022
Medicaid, OTC, Omicron, Health care, Patient, Blockchain.com, DSL, SEDAR, Population, Quality of life, Mission statement, Medicare, Logic, Cognizant, Growth, Company, Elective surgery, CEO, EBITDA, Hospice, ER, Nephrology, RHT, Cardiology, Physician, S&P/TSX Venture Composite Index, GLOBE, RTM, Pharmaceutical industry, Animal, Health insurance, COVID

We have now filed our quarterly financials for Q2 Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.

Key Points: 
  • We have now filed our quarterly financials for Q2 Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.
  • Gross Margin improved to 74% in Q2 FY2022 as compared to 58% for FY2021.
  • During the period ending December 31, 2021 and subsequent, the Company:
    Increased gross profits quarter-over-quarter to $1,583,702 in Q2 FY2022 (Q1 FY2022: $1,159,024).
  • Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTC as RQHTF.

Reliq Health Technologies, Inc. Signs Agreement with Cognizant to Expand Care Management Capabilities to Large Scale Clients

Retrieved on: 
Wednesday, January 5, 2022
ER, OTC, Patient, CTSH, WKN, Cognizant, Life, S&P/TSX Venture Composite Index, Quality of life, HIV, TSX, CEO, Blockchain.com, Partnership, Chronic care management, RHT, Health care, GLOBE, Technology, Hospital

Cognizant provides services to 300+ health systems and over 347,000 care providers who together provide care to over 200 million lives globally.

Key Points: 
  • Cognizant provides services to 300+ health systems and over 347,000 care providers who together provide care to over 200 million lives globally.
  • Reliq will continue to achieve the same or better profit margins on the Care Management component of our revenue as a result of this partnership but will be able to deploy our full-service solution (iUGO Care software plus Care Management services) to very large clients much faster.
  • This agreement will allow Reliq to access new opportunities to provide virtual care to much larger patient populations both within the US and globally.
  • The agreement with Cognizant will expand Reliqs capabilities and extend its reach, allowing Reliq to provide its iUGO Care solution to managed care organizations, large health systems and health insurance providers.

Reliq Health Technologies, Inc. Files Q1 FY2022 Quarterly Financial Statements, Provides Corporate Update

Retrieved on: 
Tuesday, November 30, 2021
Patient, Heart, Lung, CEO, Pancreas, SEDAR, HIV, United States Virgin Islands, Investment banking, RHT, Health care, Company, Medicare, EBITDA, Samsung, Chronic kidney disease, Google, Mission statement, Kidney, Cardiology, Contract, Microsoft, Hospice, Blockchain.com, CFA, Software, ER, RHC, GLOBE, CFO, Rural health clinic, S&P/TSX Venture Composite Index, OTCQB, CIO, NASDAQ, Growth, Liver, Quality of life, Pharmaceutical industry, Video game, Health insurance, Hospital

We have now filed our quarterly financials for Q1 Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. As expected, the second half of Calendar Year 2021 is proving to be a period of rapid growth for Reliq.

Key Points: 
  • We have now filed our quarterly financials for Q1 Fiscal Year 2022, said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. As expected, the second half of Calendar Year 2021 is proving to be a period of rapid growth for Reliq.
  • The Company remains on track to reach a revenue run rate of $2 Million/month by the end of Calendar Year 2021.
  • Reliq Health Technologies is a rapidly growing global medtech company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market.
  • Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

Reliq Health Technologies, Inc. to Present at Lytham Partners Fall 2021 Investor Conference

Retrieved on: 
Wednesday, September 29, 2021
ER, OTC, Blockchain.com, Conference, Webcast, Patient, WKN, GLOBE, CEO, RHT, S&P/TSX Venture Composite Index, Health care, Quality of life

HAMILTON, Ontario, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (Reliq or the Company), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it will participate in the Lytham Partners Fall 2021 Investor Conference from October 5-7.

Key Points: 
  • HAMILTON, Ontario, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (Reliq or the Company), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it will participate in the Lytham Partners Fall 2021 Investor Conference from October 5-7.
  • Reliqs CEO, Dr. Lisa Crossley, will deliver the companys latest investor presentation and engage in a fireside chat session on Tuesday, October 5, 2021 at 1:15pm ET.
  • We look forward to sharing the most recent updates on our rapidly growing business with investors at this years Lytham Partners Fall 2021 Investor Conference, said Dr. Lisa Crossley, CEO at Reliq Health.
  • Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.